| KPI | [EUR m] | Q1 2024 | FY 2024 | Q1 2025 E | FY 2025 E | FY 2026 E | FY 2027 E | FY 2028 E | FY 2029 E |
|---|---|---|---|---|---|---|---|---|---|
| Sales | Number of Estimates | 10 | 19 | 19 | 16 | 11 | 5 | ||
| Sales | Highest | 1,349.0 | 5,428.0 | 5,767.0 | 6,253.0 | 6,817.0 | 7,433.0 | ||
| Sales | Consensus | 1,291.6 | 4,998.5 | 1,329.4 | 5,248.3 | 5,570.2 | 5,929.1 | 6,309.3 | 6,795.2 |
| Sales | Median | 1,330.8 | 5,267.0 | 5,589.0 | 5,935.6 | 6,280.8 | 6,713.0 | ||
| Sales | Lowest | 1,308.2 | 5,083.1 | 5,365.3 | 5,722.0 | 6,115.8 | 6,524.0 | ||
| Price/Volume (%) | Number of Estimates | 12 | 17 | 16 | 13 | 10 | 4 | ||
| Price/Volume (%) | Highest | 3.8 | 6.0 | 6.7 | 6.9 | 7.0 | 7.0 | ||
| Price/Volume (%) | Consensus | 10.9 | 8.7 | 3.5 | 5.1 | 6.2 | 6.4 | 6.4 | 6.7 |
| Price/Volume (%) | Median | 3.5 | 5.2 | 6.3 | 6.3 | 6.4 | 6.7 | ||
| Price/Volume (%) | Lowest | 3.2 | 2.6 | 5.6 | 5.9 | 5.9 | 6.3 | ||
| M&A (%) | Number of Estimates | 9 | 13 | 13 | 12 | 10 | 4 | ||
| M&A (%) | Highest | 0.0 | 0.0 | 2.0 | 2.0 | 2.0 | 2.0 | ||
| M&A (%) | Consensus | -0.3 | -0.8 | -0.3 | -0.1 | 0.2 | 0.2 | 0.2 | 0.5 |
| M&A (%) | Median | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| M&A (%) | Lowest | -1.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| FX (%) | Number of Estimates | 9 | 13 | 13 | 12 | 10 | 4 | ||
| FX (%) | Highest | 1.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| FX (%) | Consensus | -5.6 | -2.2 | -0.1 | -0.4 | -0.1 | 0.0 | 0.0 | 0.0 |
| FX (%) | Median | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| FX (%) | Lowest | -1.9 | -2.2 | -1.3 | 0.0 | 0.0 | 0.0 | ||
| EBITDA reported | Number of Estimates | - | 19 | 19 | 15 | 10 | 4 | ||
| EBITDA reported | Highest | - | 1,153.0 | 1,276.0 | 1,376.0 | 1,427.0 | 1,524.0 | ||
| EBITDA reported | Consensus | - | 1,033.4 | - | 1,105.9 | 1,194.5 | 1,294.6 | 1,388.1 | 1,465.2 |
| EBITDA reported | Median | - | 1,105.0 | 1,194.0 | 1,288.0 | 1,391.0 | 1,474.3 | ||
| EBITDA reported | Lowest | - | 1,038.3 | 1,101.5 | 1,205.4 | 1,299.3 | 1,388.2 | ||
| EBITDA-margin (%) reported | Number of Estimates | - | 19 | 19 | 15 | 11 | 4 | ||
| EBITDA-margin (%) reported | Highest | - | 21.4 | 22.1 | 22.7 | 23.3 | 22.7 | ||
| EBITDA-margin (%) reported | Consensus | - | 20.7 | - | 21.1 | 21.4 | 21.8 | 22.0 | 21.4 |
| EBITDA-margin (%) reported | Median | - | 21.1 | 21.4 | 21.8 | 21.9 | 21.4 | ||
| EBITDA-margin (%) reported | Lowest | - | 20.4 | 20.5 | 21.1 | 20.7 | 20.0 | ||
| EBIT reported | Number of Estimates | - | 18 | 18 | 14 | 10 | 4 | ||
| EBIT reported | Highest | - | 838.0 | 940.0 | 1,059.0 | 1,136.7 | 1,220.0 | ||
| EBIT reported | Consensus | - | 717.8 | - | 797.2 | 884.9 | 978.7 | 1,059.4 | 1,108.0 |
| EBIT reported | Median | - | 800.5 | 889.8 | 986.0 | 1,063.0 | 1,110.2 | ||
| EBIT reported | Lowest | - | 729.3 | 775.6 | 858.0 | 928.2 | 991.8 | ||
| EBIT-margin (%) reported | Number of Estimates | - | 18 | 18 | 14 | 10 | 4 | ||
| EBIT-margin (%) reported | Highest | - | 15.9 | 16.9 | 17.9 | 18.4 | 18.2 | ||
| EBIT-margin (%) reported | Consensus | - | 14.4 | - | 15.2 | 15.9 | 16.5 | 16.8 | 16.2 |
| EBIT-margin (%) reported | Median | - | 15.2 | 16.0 | 16.5 | 16.6 | 15.7 | ||
| EBIT-margin (%) reported | Lowest | - | 14.3 | 14.5 | 15.0 | 15.2 | 15.2 | ||
| Profit before tax | Number of Estimates | - | 16 | 16 | 13 | 9 | 3 | ||
| Profit before tax | Highest | - | 756.0 | 885.0 | 1,014.0 | 1,107.6 | 1,146.0 | ||
| Profit before tax | Consensus | - | 645.8 | - | 721.3 | 815.4 | 919.0 | 1,006.6 | 1,038.5 |
| Profit before tax | Median | - | 726.7 | 826.5 | 930.0 | 995.9 | 1,047.8 | ||
| Profit before tax | Lowest | - | 659.3 | 705.6 | 788.0 | 858.2 | 921.8 | ||
| Reported Income for the year | Number of Estimates | - | 17 | 17 | 14 | 10 | 4 | ||
| Reported Income for the year | Highest | - | 560.0 | 655.0 | 750.0 | 821.0 | 847.0 | ||
| Reported Income for the year | Consensus | - | 478.2 | - | 532.3 | 601.7 | 678.7 | 742.0 | 766.9 |
| Reported Income for the year | Median | - | 537.0 | 604.0 | 685.3 | 734.4 | 771.9 | ||
| Reported Income for the year | Lowest | - | 486.5 | 518.8 | 578.6 | 630.2 | 676.8 | ||
| Average number of shares (in million) | Number of Estimates | - | 23 | 23 | 22 | 22 | 22 | ||
| Average number of shares (in million) | Highest | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 | ||
| Average number of shares (in million) | Consensus | - | 139.77 | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 |
| Average number of shares (in million) | Median | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 | ||
| Average number of shares (in million) | Lowest | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 | ||
| EPS attributable to the shareholders of Symrise - basic reported | Number of Estimates | - | 17 | 17 | 14 | 10 | 4 | ||
| EPS attributable to the shareholders of Symrise - basic reported | Highest | - | 4.01 | 4.69 | 5.37 | 5.87 | 6.06 | ||
| EPS attributable to the shareholders of Symrise - basic reported | Consensus | - | 3.42 | - | 3.81 | 4.30 | 4.86 | 5.31 | 5.49 |
| EPS attributable to the shareholders of Symrise - basic reported | Median | - | 3.84 | 4.32 | 4.90 | 5.25 | 5.52 | ||
| EPS attributable to the shareholders of Symrise - basic reported | Lowest | - | 3.48 | 3.71 | 4.14 | 4.51 | 4.84 | ||
| Dividend | Number of Estimates | - | 17 | 17 | 14 | 9 | 3 | ||
| Dividend | Highest | - | 1.54 | 1.73 | 1.89 | 2.07 | 1.76 | ||
| Dividend | Consensus | - | 1.20 | - | 1.31 | 1.44 | 1.59 | 1.67 | 1.59 |
| Dividend | Median | - | 1.30 | 1.40 | 1.55 | 1.60 | 1.70 | ||
| Dividend | Lowest | - | 1.15 | 1.15 | 1.30 | 1.30 | 1.30 | ||
| Scent & Care, Sales | Number of Estimates | 9 | 13 | 12 | 10 | 7 | 2 | ||
| Scent & Care, Sales | Highest | 530.2 | 2,012.8 | 2,133.5 | 2,261.5 | 2,397.2 | 2,526.8 | ||
| Scent & Care, Sales | Consensus | 516.4 | 1,907.8 | 523.6 | 1,982.0 | 2,087.3 | 2,204.6 | 2,329.6 | 2,468.8 |
| Scent & Care, Sales | Median | 526.3 | 1,984.0 | 2,085.1 | 2,194.5 | 2,323.1 | 2,468.8 | ||
| Scent & Care, Sales | Lowest | 511.0 | 1,920.7 | 2,044.5 | 2,161.1 | 2,284.3 | 2,410.7 | ||
| Scent & Care Price/Volume (%) | Number of Estimates | 11 | 13 | 12 | 10 | 7 | 2 | ||
| Scent & Care Price/Volume (%) | Highest | 3.5 | 5.5 | 6.5 | 6.9 | 7.5 | 7.5 | ||
| Scent & Care Price/Volume (%) | Consensus | 16.9 | 10.2 | 1.9 | 4.5 | 5.6 | 5.6 | 5.8 | 6.3 |
| Scent & Care Price/Volume (%) | Median | 2.0 | 4.8 | 5.5 | 5.5 | 5.5 | 6.3 | ||
| Scent & Care Price/Volume (%) | Lowest | -0.1 | 2.0 | 5.0 | 5.0 | 5.0 | 5.0 | ||
| Scent & Care M&A (%) | Number of Estimates | 8 | 11 | 10 | 10 | 7 | 2 | ||
| Scent & Care M&A (%) | Highest | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.0 | ||
| Scent & Care M&A (%) | Consensus | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Scent & Care M&A (%) | Median | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Scent & Care M&A (%) | Lowest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Scent & Care FX (%) | Number of Estimates | 8 | 11 | 10 | 10 | 7 | 2 | ||
| Scent & Care FX (%) | Highest | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Scent & Care FX (%) | Consensus | -3.1 | -1.3 | -0.4 | -0.5 | -0.2 | 0.0 | 0.0 | 0.0 |
| Scent & Care FX (%) | Median | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Scent & Care FX (%) | Lowest | -1.9 | -2.2 | -1.4 | 0.0 | 0.0 | 0.0 | ||
| Scent & Care, EBITDA reported | Number of Estimates | - | 14 | 13 | 10 | 7 | 2 | ||
| Scent & Care, EBITDA reported | Highest | - | 387.0 | 432.0 | 461.1 | 509.7 | 482.9 | ||
| Scent & Care, EBITDA reported | Consensus | - | 347.0 | - | 374.2 | 406.6 | 436.6 | 469.2 | 478.4 |
| Scent & Care, EBITDA reported | Median | - | 374.2 | 406.1 | 436.7 | 464.6 | 478.4 | ||
| Scent & Care, EBITDA reported | Lowest | - | 348.7 | 377.6 | 410.1 | 440.8 | 473.9 | ||
| Scent & Care, EBITDA-margin (%) reported | Number of Estimates | - | 13 | 12 | 10 | 7 | 2 | ||
| Scent & Care, EBITDA-margin (%) reported | Highest | - | 19.2 | 20.0 | 20.9 | 21.9 | 20.0 | ||
| Scent & Care, EBITDA-margin (%) reported | Consensus | - | 18.2 | - | 18.8 | 19.4 | 19.8 | 20.1 | 19.4 |
| Scent & Care, EBITDA-margin (%) reported | Median | - | 18.8 | 19.4 | 19.7 | 19.7 | 19.4 | ||
| Scent & Care, EBITDA-margin (%) reported | Lowest | - | 18.2 | 18.5 | 18.8 | 18.8 | 18.8 | ||
| Taste, Nutrition & Health, Sales | Number of Estimates | 9 | 13 | 12 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health, Sales | Highest | 813.9 | 3,295.0 | 3,522.0 | 3,771.7 | 4,054.6 | 4,358.7 | ||
| Taste, Nutrition & Health, Sales | Consensus | 775.2 | 3,090.7 | 803.6 | 3,241.8 | 3,447.1 | 3,687.9 | 3,916.5 | 4,184.4 |
| Taste, Nutrition & Health, Sales | Median | 808.4 | 3,260.7 | 3,464.7 | 3,696.2 | 3,900.8 | 4,184.4 | ||
| Taste, Nutrition & Health, Sales | Lowest | 787.1 | 3,162.4 | 3,319.7 | 3,535.5 | 3,765.3 | 4,010.0 | ||
| Taste, Nutrition & Health Price/Volume (%) | Number of Estimates | 11 | 13 | 12 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health Price/Volume (%) | Highest | 6.3 | 6.6 | 7.5 | 7.5 | 7.5 | 7.5 | ||
| Taste, Nutrition & Health Price/Volume (%) | Consensus | 7.5 | 7.8 | 4.6 | 5.5 | 6.6 | 6.8 | 6.8 | 7.0 |
| Taste, Nutrition & Health Price/Volume (%) | Median | 4.5 | 5.5 | 6.8 | 6.9 | 6.7 | 7.0 | ||
| Taste, Nutrition & Health Price/Volume (%) | Lowest | 3.4 | 3.0 | 5.0 | 6.0 | 6.0 | 6.5 | ||
| Taste, Nutrition & Health M&A (%) | Number of Estimates | 8 | 11 | 10 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health M&A (%) | Highest | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.0 | ||
| Taste, Nutrition & Health M&A (%) | Consensus | -0.5 | -1.3 | -0.6 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Taste, Nutrition & Health M&A (%) | Median | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Taste, Nutrition & Health M&A (%) | Lowest | -1.7 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Taste, Nutrition & Health FX (%) | Number of Estimates | 8 | 11 | 10 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health FX (%) | Highest | 0.9 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Taste, Nutrition & Health FX (%) | Consensus | -7.1 | -2.7 | -0.1 | -0.3 | -0.1 | 0.0 | 0.0 | 0.0 |
| Taste, Nutrition & Health FX (%) | Median | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Taste, Nutrition & Health FX (%) | Lowest | -1.9 | -2.2 | -1.3 | 0.0 | 0.0 | 0.0 | ||
| Taste, Nutrition & Health, EBITDA reported | Number of Estimates | - | 14 | 13 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health, EBITDA reported | Highest | - | 748.0 | 810.0 | 882.9 | 960.4 | 976.6 | ||
| Taste, Nutrition & Health, EBITDA reported | Consensus | - | 686.4 | - | 729.2 | 786.7 | 851.7 | 912.5 | 945.5 |
| Taste, Nutrition & Health, EBITDA reported | Median | - | 733.1 | 788.0 | 853.5 | 908.7 | 945.5 | ||
| Taste, Nutrition & Health, EBITDA reported | Lowest | - | 689.6 | 723.9 | 795.3 | 858.5 | 914.3 | ||
| Taste, Nutrition & Health, EBITDA-margin (%) reported | Number of Estimates | - | 13 | 12 | 10 | 7 | 2 | ||
| Taste, Nutrition & Health, EBITDA-margin (%) reported | Highest | - | 22.9 | 23.4 | 23.9 | 24.3 | 22.8 | ||
| Taste, Nutrition & Health, EBITDA-margin (%) reported | Consensus | - | 22.2 | - | 22.5 | 22.8 | 23.1 | 23.3 | 22.6 |
| Taste, Nutrition & Health, EBITDA-margin (%) reported | Median | - | 22.5 | 22.8 | 23.1 | 23.2 | 22.6 | ||
| Taste, Nutrition & Health, EBITDA-margin (%) reported | Lowest | - | 21.8 | 21.8 | 22.4 | 22.4 | 22.4 |
This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
